Similar articles for PMID: 28623367

Year	Number of Results
1973	1
1999	1
2005	1
2008	1
2010	1
2011	2
2012	2
2013	5
2014	11
2015	19
2016	17
2017	24
2018	21
2019	9
2020	6
2021	1
2023	2
2024	0

1

Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative.

Hutton ML, Cunningham BA, Mackin KE, Lyon SA, James ML, Rood JI, Lyras D. Hutton ML, et al. Sci Rep. 2017 Jun 16;7(1):3665. doi: 10.1038/s41598-017-03982-5. Sci Rep. 2017. PMID: 28623367 Free PMC article.

2

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.

Qiu H, Cassan R, Johnstone D, Han X, Joyee AG, McQuoid M, Masi A, Merluza J, Hrehorak B, Reid R, Kennedy K, Tighe B, Rak C, Leonhardt M, Dupas B, Saward L, Berry JD, Nykiforuk CL. Qiu H, et al. PLoS One. 2016 Jun 23;11(6):e0157970. doi: 10.1371/journal.pone.0157970. eCollection 2016. PLoS One. 2016. PMID: 27336843 Free PMC article.

3

Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection.

Sponseller JK, Steele JA, Schmidt DJ, Kim HB, Beamer G, Sun X, Tzipori S. Sponseller JK, et al. J Infect Dis. 2015 Apr 15;211(8):1334-41. doi: 10.1093/infdis/jiu605. Epub 2014 Nov 7. J Infect Dis. 2015. PMID: 25381448 Free PMC article.

4

Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.

Yang Z, Ramsey J, Hamza T, Zhang Y, Li S, Yfantis HG, Lee D, Hernandez LD, Seghezzi W, Furneisen JM, Davis NM, Therien AG, Feng H. Yang Z, et al. Infect Immun. 2015 Feb;83(2):822-31. doi: 10.1128/IAI.02897-14. Epub 2014 Dec 8. Infect Immun. 2015. PMID: 25486992 Free PMC article.

5

Characterization of Chicken IgY Specific to Clostridium difficile R20291 Spores and the Effect of Oral Administration in Mouse Models of Initiation and Recurrent Disease.

Pizarro-Guajardo M, Díaz-González F, Álvarez-Lobos M, Paredes-Sabja D. Pizarro-Guajardo M, et al. Front Cell Infect Microbiol. 2017 Aug 14;7:365. doi: 10.3389/fcimb.2017.00365. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28856119 Free PMC article.

6

Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.

Warn P, Thommes P, Sattar A, Corbett D, Flattery A, Zhang Z, Black T, Hernandez LD, Therien AG. Warn P, et al. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6471-6482. doi: 10.1128/AAC.00974-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27527088 Free PMC article.

7

Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model.

Heidebrecht HJ, Weiss WJ, Pulse M, Lange A, Gisch K, Kliem H, Mann S, Pfaffl MW, Kulozik U, von Eichel-Streiber C. Heidebrecht HJ, et al. Toxins (Basel). 2019 Feb 6;11(2):98. doi: 10.3390/toxins11020098. Toxins (Basel). 2019. PMID: 30736358 Free PMC article.

8

Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.

Tian JH, Glenn G, Flyer D, Zhou B, Liu Y, Sullivan E, Wu H, Cummings JF, Elllingsworth L, Smith G. Tian JH, et al. Vaccine. 2017 Jul 24;35(33):4079-4087. doi: 10.1016/j.vaccine.2017.06.062. Epub 2017 Jun 29. Vaccine. 2017. PMID: 28669616 Free article.

9

Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.

Kufel WD, Devanathan AS, Marx AH, Weber DJ, Daniels LM. Kufel WD, et al. Pharmacotherapy. 2017 Oct;37(10):1298-1308. doi: 10.1002/phar.1990. Epub 2017 Sep 12. Pharmacotherapy. 2017. PMID: 28730660 Review.

10

Deciphering the domain specificity of C. difficile toxin neutralizing antibodies.

Cole LE, Li L, Jetley U, Zhang J, Pacheco K, Ma F, Zhang J, Mundle S, Yan Y, Barone L, Rogers C, Beltraminelli N, Quemeneur L, Kleanthous H, Anderson SF, Anosova NG. Cole LE, et al. Vaccine. 2019 Jun 27;37(29):3892-3901. doi: 10.1016/j.vaccine.2019.05.040. Epub 2019 May 20. Vaccine. 2019. PMID: 31122858 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year